U-M Center for RNA Biomedicine hosts Moderna vaccine seminar

February 23, 2021
Contact: Morgan Sherburne morganls@umich.edu

EVENT ANNOUNCEMENT

DATE: 4-5 p.m. Wednesday, March 3

EVENT: “A timely confluence: The backstory of Moderna’s COVID-19 vaccine”

Melissa Moore, chief scientific officer at Moderna Therapeutics, will speak at a virtual seminar hosted by the University of Michigan Center for RNA Biomedicine as part of the worldwide RNA Collaborative Seminar Series. Under Moore’s scientific leadership, Moderna Therapeutics developed one of the two mRNA-based vaccines authorized for use in the United States.

Researchers have been studying and working with mRNA vaccines for decades, in particular for flu, Zika, rabies and cytomegalovirus. Interest has grown in these vaccines because they can be developed in a laboratory using readily available sequence information and biological materials. This means the development process can be quickly standardized and scaled up, making vaccine development faster than traditional methods of making vaccines.

The talk will be geared toward the general public, and Moore will take live questions.

PLACE: The virtual event is open to the public.

RSVP: Those interested in watching via Zoom can register online.

SPONSORS: U-M Center for RNA Biomedicine within the RNA Collaborative Seminar Series. The Collaborative is supported by the RNA Society.